Showing results (31-40 of 966) with videos related to
Sort By:
Pageof 97
Drugs in Context|January 20, 2015
The cost of biologics for psoriasis is increasingJudy Cheng, Steven R FeldmanCutis|June 8, 2011
Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implicationsSteven R Feldman, Alan B FleischerJournal of Drugs in Dermatology : JDD|June 23, 2009
Are ointments better than other vehicles for corticosteroid treatment of psoriasis?Anna H Zivkovich, Steven R FeldmanExpert Opinion on Pharmacotherapy|January 26, 2006
Cost-effectiveness of moderate-to-severe psoriasis treatmentDrew W Miller, Steven R FeldmanJournal of Cutaneous Medicine and Surgery|December 16, 2024
Indoor Tanning Addiction: Biological Mechanisms and Association with Other DisordersOlivia C LaMonte, Steven R FeldmanDermatology Online Journal|November 19, 2019
Unilateral contact dermatitis of the chestLeena T Ramani, Steven R FeldmanJournal of Drugs in Dermatology : JDD|May 9, 2013
Combination therapy for psoriasis in the United StatesScott A Davis, Steven R FeldmanThe Journal of Dermatological Treatment|November 1, 2013
Patterns of ambulatory care usage and leading treatments for rosaceaScott A Davis, Steven R FeldmanPediatric Dermatology|January 10, 2018
Rapid, successful treatment of atopic dermatitis recalcitrant to topical corticosteroidsDaniel J Lewis, Steven R FeldmanJournal of Drugs in Dermatology : JDD|January 5, 2021
Ingenol Mebutate and the Treatment of Actinic KeratosisCourtney E Heron, Steven R FeldmanPageof 97